Literature DB >> 33451033

The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?

Simone Bini1, Laura D'Erasmo1, Alessia Di Costanzo1, Ilenia Minicocci1, Valeria Pecce1, Marcello Arca1.   

Abstract

Angiopoietin-like proteins, namely ANGPTL3-4-8, are known as regulators of lipid metabolism. However, recent evidence points towards their involvement in the regulation of adipose tissue function. Alteration of adipose tissue functions (also called adiposopathy) is considered the main inducer of metabolic syndrome (MS) and its related complications. In this review, we intended to analyze available evidence derived from experimental and human investigations highlighting the contribution of ANGPTLs in the regulation of adipocyte metabolism, as well as their potential role in common cardiometabolic alterations associated with adiposopathy. We finally propose a model of ANGPTLs-based adipose tissue dysfunction, possibly linking abnormalities in the angiopoietins to the induction of adiposopathy and its related disorders.

Entities:  

Keywords:  ANGPTL3; ANGPTL4; ANGPTL8; adipose tissue; adiposopathy; brown adipose tissue

Mesh:

Substances:

Year:  2021        PMID: 33451033      PMCID: PMC7828552          DOI: 10.3390/ijms22020742

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  112 in total

1.  Sleep Loss Disrupts Morning-to-Evening Differences in Human White Adipose Tissue Transcriptome.

Authors:  Britta Wilms; Elena M Leineweber; Matthias Mölle; Rodrigo Chamorro; Claudia Pommerenke; Gabriela Salinas-Riester; Christian Sina; Hendrik Lehnert; Henrik Oster; Sebastian M Schmid
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.

Authors:  Yu-Xin Xu; Valeska Redon; Haojie Yu; William Querbes; James Pirruccello; Abigail Liebow; Amy Deik; Kevin Trindade; Xiao Wang; Kiran Musunuru; Clary B Clish; Chad Cowan; Kevin Fizgerald; Daniel Rader; Sekar Kathiresan
Journal:  Atherosclerosis       Date:  2017-09-21       Impact factor: 5.162

3.  Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.

Authors:  Ilenia Minicocci; Sara Santini; Vito Cantisani; Nathan Stitziel; Sekar Kathiresan; Juan Antonio Arroyo; Gertrudis Martí; Livia Pisciotta; Davide Noto; Angelo B Cefalù; Marianna Maranghi; Giancarlo Labbadia; Giovanni Pigna; Fabio Pannozzo; Fabrizio Ceci; Ester Ciociola; Stefano Bertolini; Sebastiano Calandra; Patrizia Tarugi; Maurizio Averna; Marcello Arca
Journal:  J Lipid Res       Date:  2013-09-20       Impact factor: 5.922

4.  Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition.

Authors:  Raghavendra Mysore; Gerhard Liebisch; You Zhou; Vesa M Olkkonen; P A Nidhina Haridas
Journal:  Chem Phys Lipids       Date:  2017-05-18       Impact factor: 3.329

5.  Angptl3 regulates lipid metabolism in mice.

Authors:  Ryuta Koishi; Yosuke Ando; Mitsuru Ono; Mitsuru Shimamura; Hiroaki Yasumo; Toshihiko Fujiwara; Hiroyoshi Horikoshi; Hidehiko Furukawa
Journal:  Nat Genet       Date:  2002-01-14       Impact factor: 38.330

6.  Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.

Authors:  Yoshihisa Okamoto; Eduardo J Folco; Manabu Minami; A K Wara; Mark W Feinberg; Galina K Sukhova; Richard A Colvin; Shinji Kihara; Tohru Funahashi; Andrew D Luster; Peter Libby
Journal:  Circ Res       Date:  2007-11-08       Impact factor: 17.367

Review 7.  Unraveling the multiple roles of leptin in inflammation and autoimmunity.

Authors:  Antonio La Cava; Carlo Alviggi; Giuseppe Matarese
Journal:  J Mol Med (Berl)       Date:  2003-10-10       Impact factor: 4.599

8.  Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.

Authors:  Suneil K Koliwad; Taiyi Kuo; Lauren E Shipp; Nora E Gray; Fredrik Backhed; Alex Yick-Lun So; Robert V Farese; Jen-Chywan Wang
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

9.  Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.

Authors:  Ilenia Minicocci; Anna Tikka; Eleonora Poggiogalle; Jari Metso; Anna Montali; Fabrizio Ceci; Giancarlo Labbadia; Mario Fontana; Alessia Di Costanzo; Marianna Maranghi; Aldo Rosano; Christian Ehnholm; Lorenzo Maria Donini; Matti Jauhiainen; Marcello Arca
Journal:  J Lipid Res       Date:  2016-04-03       Impact factor: 5.922

10.  A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.

Authors:  Zhiyao Fu; Abdul B Abou-Samra; Ren Zhang
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

View more
  6 in total

Review 1.  The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.

Authors:  Alessandra Pinzon Grimaldos; Simone Bini; Ilenia Pacella; Alessandra Rossi; Alessia Di Costanzo; Ilenia Minicocci; Laura D'Erasmo; Marcello Arca; Silvia Piconese
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

2.  Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study.

Authors:  Maria C Foss-Freitas; Baris Akinci; Adam Neidert; Victoria J Bartlett; Eunju Hurh; Ewa Karwatowska-Prokopczuk; Elif A Oral
Journal:  Lipids Health Dis       Date:  2021-12-05       Impact factor: 3.876

Review 3.  Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS).

Authors:  Laura D'Erasmo; Simone Bini; Marcello Arca
Journal:  Curr Atheroscler Rep       Date:  2021-09-01       Impact factor: 5.113

4.  ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.

Authors:  Fu Zhong; Shurao Liu; Yue Li; Xia Gao; Guanyu Li; Ming Liu; Jingzhi Wang; Weijing Cui; Yanhong Suo
Journal:  Lipids Health Dis       Date:  2022-04-10       Impact factor: 3.876

5.  The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway.

Authors:  Simone Bini; Valeria Pecce; Alessia Di Costanzo; Luca Polito; Ameneh Ghadiri; Ilenia Minicocci; Federica Tambaro; Stella Covino; Marcello Arca; Laura D'Erasmo
Journal:  Biomolecules       Date:  2022-04-16

6.  Increased expression level of ANGPTL8 in white adipose tissue under acute and chronic cold treatment.

Authors:  Hossein Arefanian; Irina Al-Khairi; Nermeen Abu Khalaf; Preethi Cherian; Sina Kavalakatt; Dhanya Madhu; Aditi Mathur; Mohamed G Qaddoumi; Fahd Al-Mulla; Jehad Abubaker; Mohamed Abu-Farha
Journal:  Lipids Health Dis       Date:  2021-09-26       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.